Valuation: Johnson & Johnson

Market Cap 645B 576B 532B 482B 902B 61,221B 917B 6,402B 2,535B 32,076B 2,420B 2,369B 101,126B P/E 2026 *
39.2x
P/E 2027 * 26.6x
Enterprise Value 667B 596B 550B 499B 933B 63,333B 949B 6,623B 2,622B 33,182B 2,504B 2,451B 104,615B EV / Sales 2026 *
6.59x
EV / Sales 2027 * 6.13x
Free-Float
76.38%
Yield 2026 *
1.99%
Yield 2027 * 2.09%
1 day-1.63%
1 week+3.33%
Current month-0.25%
1 month-1.89%
3 months+1.85%
6 months+14.49%
Current year+27.60%
1 week 251.5
Extreme 251.5
269.67
1 month 245.17
Extreme 245.17
275.23
Current year 200.91
Extreme 200.9101
281.07
1 year 184.66
Extreme 184.66
281.07
3 years 140.68
Extreme 140.68
281.07
5 years 140.68
Extreme 140.68
281.07
10 years 109.16
Extreme 109.16
281.07
Manager TitleAgeSince
Chief Executive Officer 63 02/01/2022
Director of Finance/CFO 59 30/06/2018
Chief Tech/Sci/R&D Officer 61 31/07/2024
Director TitleAgeSince
Director/Board Member 62 14/10/2013
Director/Board Member 71 08/06/2015
Chairman 63 01/01/2023
Date Insider Type Main position Quantity % Market Cap. Importance
08/09/26 Free

Director

136 0.0000%
08/09/26 Free

Director

181 0.0000%
08/09/26 Free

Director

113 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.63%+3.33%+37.20%+74.43% 645B
-1.89%+1.44%+55.30%+121.12% 1,165B
-0.26%+0.06%+25.12%+97.33% 504B
-0.31%+3.09%+43.92%+64.55% 380B
-1.02%-0.58%+66.45%+40.41% 363B
-0.68%+2.65%+22.46%+51.48% 297B
-1.20%+0.99%+2.26%+22.95% 269B
-1.81%+1.70%+50.17%+61.08% 237B
-0.71%-0.00%+29.36%+101.37% 195B
-1.74%+0.21%-24.15%-61.87% 175B
Average -1.12%+2.46%+30.81%+57.29% 423.09B
Weighted average by Cap. -1.24%+3.13%+38.42%+76.16%

Financials

2026 *2027 *
Net sales 101B 90.39B 83.5B 75.67B 142B 9,609B 144B 1,005B 398B 5,034B 380B 372B 15,872B 108B 96.27B 88.93B 80.59B 151B 10,234B 153B 1,070B 424B 5,362B 405B 396B 16,904B
Net income 16.56B 14.79B 13.66B 12.38B 23.16B 1,572B 23.54B 164B 65.08B 824B 62.14B 60.82B 2,596B 23.79B 21.25B 19.63B 17.79B 33.28B 2,259B 33.83B 236B 93.51B 1,183B 89.29B 87.4B 3,731B
Net Debt 22.25B 19.87B 18.35B 16.63B 31.12B 2,112B 31.63B 221B 87.45B 1,107B 83.5B 81.72B 3,489B 16.22B 14.49B 13.38B 12.13B 22.69B 1,540B 23.06B 161B 63.76B 807B 60.88B 59.58B 2,544B
Projected Income Statement - Annual - Johnson & Johnson
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2025, Johnson & Johnson has 63 manufacturing facilities located in the United States (22), North America (7), Europe (22), Africa and Asia/Pacific (12). The United States accounts for 57.1% of net sales.
Employees
138,200
Date Price Change Volume
23/10/26 US$263.81 -1.42% 5,307,717
22/10/26 US$267.61 +3.81% 10,134,968
21/10/26 US$257.78 -0.61% 6,557,023
20/10/26 US$259.36 +2.19% 7,664,270
19/10/26 US$253.79 -0.69% 8,847,935
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Johnson & Johnson
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
267.61USD
Average target price
279.41USD
Spread / Average Target
+4.41%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Johnson & Johnson